by MEGIN | Jul 25, 2022 | MEGIN News
This month, MEGIN is delighted to be among the delegate of leading UK HealthTech innovators heading to Tennessee to strengthen trade links and showcase their products and services to the US market. The visit marks the second major US trade mission organised this year...
by MEGIN | Mar 22, 2022 | MEGIN News
MEGIN is excited to be among the delegate of pioneering HealthTech companies heading to Texas as part of the first major US trade mission organized by the Association of British HealthTech Industries (ABHI) since the COVID-19 pandemic. The visit marks the launch of a...
by MEGIN | Feb 28, 2022 | MEGIN News
HELSINKI, FINLAND (March 07, 2022) – MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the University of Nebraska Medical Center (UNMC). UNMC scientists and clinicians are at the...
by MEGIN | Feb 18, 2022 | MEGIN News
It’s a first in Switzerland: the Human Neuroscience Platform (HNP) now hosts a magnetoencephalography (MEG) facility with the purchase of a MEGIN TRIUX™ neo, a state-of-the-art scanner that allows non-invasive analysis of brain activity. This acquisition is the result...
by MEGIN | Jan 27, 2022 | MEGIN News
MEGIN is pleased to announce the sale of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, to the Norman Fixel Institute for Neurological Diseases at University of Florida Health (UF Health). The Norman Fixel Institute coordinates the...
by MEGIN | Jan 18, 2022 | MEGIN News
MEGIN is delighted to be joining the Association of British HealthTech Industries (ABHI) UK Pavilion at Arab Health 2022, which is taking place from 24- 27 January in Dubai. The exhibition – the largest event of its kind in the Middle East – will showcase more than...
